Objective-Recent studies have suggested that arterial and venous thrombosis share common risk factors. Although carotid atherosclerosis is associated with arterial cardiovascular events, its role in venous thromboembolic disease is unclear. We wanted to investigate and compare the effect of carotid atherosclerosis on the risk of myocardial infarction (MI) and venous thromboembolism (VTE) in a general population, taking into account competing risks. Approach and Results-Mean intima-media thickness and total plaque area in the right carotid artery were measured with ultrasound in 6257 people aged 25 to 84 years who participated in a population-based health study, the Tromsø Study, from 1994 to 1995. Incident MI and VTE events were registered from date of enrollment to end of follow-up on December 31, 2010. Cox proportional hazards regression models using age as time scale were used to estimate causespecific hazard ratios with 95% confidence intervals for MI and VTE by increasing levels of intima-media thickness and total plaque area. There were 894 incident MI cases and 256 VTE events during a median of 15.4 years of follow-up. The risk of MI increased significantly across quartiles of mean intima-media thickness (P for trend <0.001) and with increasing total plaque area (P for trend <0.001), but neither intima-media thickness (P for trend=0.94) nor total plaque area (P for trend=0.45) was associated with VTE risk in multivariable-adjusted analysis. Conclusions-In this study, carotid atherosclerosis was strongly associated with future MI but not with VTE. Our findings suggest that carotid atherosclerosis does not represent a link between arterial and venous thrombosis. (Arterioscler Thromb Vasc Biol. 2014;34:226-230.) The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
R ecent studies have demonstrated an association between arterial cardiovascular disease and venous thromboembolism (VTE), 1,2 but the mechanisms underlying these observations are not fully clarified. The 2 conditions share common risk factors, such as age, 3 obesity, 3, 4 and family history of myocardial infarction (MI), 4, 5 but the effect of traditional atherosclerotic risk factors, such as hypertension, dyslipidemia, smoking, and diabetes mellitus, on the risk of VTE remains controversial. 1, 3, 6 On the arterial side, ultrasonographic measurements of intima-media thickness (IMT) and the presence of plaques in the carotid arteries are widely used as surrogate markers of cardiovascular disease. The presence of carotid atherosclerosis, as measured by IMT and total plaque area (TPA), is strongly associated with future arterial cardiovascular events. [7] [8] [9] Prandoni et al 2 also found a higher prevalence of carotid atherosclerosis in patients with unprovoked VTE than in age-matched and sex-matched hospitalized controls. Because atherosclerosis is associated with activation of platelets, blood coagulation, and increased fibrin turnover, 10 it is plausible that such a procoagulant state may trigger VTE. However, later prospective studies failed to confirm an association between carotid atherosclerosis and future risk of VTE. 11, 12 A competing risk approach to calculate cause-specific hazards for 2 possibly interrelated diseases has several advantages. Calculating failure time to the first event eliminates the opportunity that one event alters the risk of another and that apparent common risk factors are confounders by acting as a proxy for cause. Furthermore, confirmation of the already established relationship between carotid atherosclerosis and risk of MI also ensures appropriate measurement and classification of the exposure variable (carotid atherosclerosis measures). To date, no other study has examined the effect of carotid atherosclerosis on VTE risk while accounting for the competing risk of MI. In the present cohort study, we sought to assess the effect of carotid atherosclerosis, as measured by IMT and TPA, on the risk of future MI and VTE in a general population using a competing risk model.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
The mean baseline age was 59.9 years (range, 25-84 years; standard deviation [SD], 10.3 years), and 52.2% (n=3264) were women. During a median follow-up of 15.4 years, there were 894 incident MIs and 256 incident VTEs. Thirty-nine participants experienced development of both MI and VTE during follow-up, of which 28 had MI and 11 had VTE as their first event, respectively. The overall crude incidence rates were 11.4 (95% confidence interval [CI], 10.7-12.2) per 1000 person-years for MI and 3.3 (95% CI, 2.9-3.7) per 1000 person-years for VTE. Table 1 shows the baseline distribution of atherosclerotic risk factors in participants who did not develop any event during follow-up and in those who developed MI and VTE, respectively. People who experienced either an MI or a VTE event were older and had a higher body mass index and higher total cholesterol than did those who did not experience an event during follow-up. Participants with MI were more frequently men, had diabetes mellitus, were smokers, and had higher triglycerides and lower high-density lipoprotein cholesterol. Hypertension was most prevalent among participants with MI, followed by participants with VTE.
Plaques were present in 2985 participants (47.9%) at baseline. Table 2 shows crude incidence rates and cause-specific hazard ratios (HR) with 95% CI for MI and VTE by plaque status (no plaque and tertiles of TPA). Using age as a time scale, increasing TPA was associated with MI risk (P for trend <0.001) in both crude analysis and after adjustment for sex, total cholesterol, high-density lipoprotein cholesterol, body mass index, smoking, diabetes mellitus, and hypertension (P for trend <0.001). In multivariable analysis, participants in the upper tertile of TPA had a 1.70-fold increase in MI risk compared with participants without plaques at baseline (95% CI, 1.42-2.03; Table 2 ). In contrast, TPA was not associated with VTE in either crude-adjusted or multivariable-adjusted analysis ( Table 2 ). Excluding participants with high TPA measurements (values ≥2 SD above the upper tertile mean) did not alter the risk estimates (results not shown).
Comparable findings were observed for mean IMT (Table 3) . IMT was significantly associated with MI in both crude-adjusted and multivariable-adjusted analyses (P for trend <0.001), with an HR of 1.88 (95% CI, 1.45-2.459) for participants in the upper quartile versus the lower quartile of mean IMT. In contrast, IMT was not associated with VTE risk in either crude-adjusted or multivariable-adjusted analysis (P for trend=0.82 and 0.57, respectively). When examining IMT as a continuous variable, results were similar. Increasing IMT remained associated with MI after multivariable adjustment (HR per 1-SD increase in IMT 1.17 [95% CI, 1.10-1.25]) but not with VTE (HR per 1-SD increase in IMT 0.94 [95% CI, 0.81-1.09]; Table 3 ). Comparable results were found for plaque-free mean common carotid artery far wall IMT, which was associated with MI after multivariable adjustment (HR per 1-SD increase in mean common carotid artery far wall IMT, 1.10 [95% CI, 1.03-1.17]) but not with VTE (HR per 1-SD increase in mean common carotid artery far wall IMT, 1.02 [95% CI, 0.90-1.17]; data not shown in Table) .
Examining the assumption of proportional hazards using Schoenfeld residuals revealed that IMT violated the assumption of proportional hazards, suggesting that the effect of IMT is time-dependent (ie, dependent on age). To assess this association, we examined the risk of MI in people younger than and older than 60 years of age. In agreement with previous reports, 13 
Discussion
In this study, carotid atherosclerosis, as measured by carotid IMT and TPA, was clearly associated with risk of future MI but not with VTE. The risk estimates for MI increased over levels of IMT and TPA in both crude and multivariable-adjusted analyses, whereas no such trend was observed for VTE. Calculating cause-specific hazards to account for competing risks has several advantages when examining risk factors for interrelated diseases. By eliminating the possibility of one outcome influencing the risk of another, the direct effect of the risk factors in question on each outcome is assessed. Comparison within the same population also ensures that the degree of possible confounding is similar for the 2 outcomes. In our study, the risk estimates for MI by carotid atherosclerosis were similar to that of other cohorts, [13] [14] [15] suggesting that the nonassociative nature of carotid atherosclerosis and VTE is not explained by unrecognized confounding or inappropriate measurement and classification of the exposure variable (carotid atherosclerosis measures).
For both TPA and IMT, our MI risk estimates are in agreement with those of previous reports. In a large meta-analysis including 37 197 participants, Lorenz et al 8 found an overall age-adjusted and sex-adjusted HR for MI of 1.26 (95% CI, 1.21-1.30) per 1-SD difference in common carotid artery IMT. Similar findings were recently published from the PROG-IMT collaborative project, in which the mean IMT of 2 separate carotid scans was associated with future MI after multivariable adjustment (HR, 1.22; 95% CI, 1.14-1.30). 15 For a combined cardiovascular end point (MI, stroke, aortic aneurism, angina pectoris, or revascularization procedures), the presence of carotid plaques had a predictive odds ratio of 2.09 (95% CI, 1.05-4.16). 16 Our null findings for VTE are in concurrence with those of 2 large population-based prospective studies (the Atherosclerosis Risk in Communities and the Cardiovascular Health Study) in which subclinical atherosclerosis was evaluated as a VTE risk factor in participants younger than and older than 65 years, respectively. 11, 12 In the former study, neither increased IMT nor the presence of carotid plaque was associated with VTE risk in 13 081 participants after a mean follow-up of 12.5 years. 11 In the latter study, IMT and plaque measurements were supplemented with registration of major ECG abnormalities and ankle brachial index registration as manifestations of subclinical atherosclerosis in an older cohort of 4108 people. During follow-up, none of these atherosclerosis measures was associated with increased risk of total or unprovoked VTE. Surprisingly, both high-risk carotid plaques and the highest internal carotid artery IMT quartile were inversely associated with VTE risk. 12 Prandoni et al 2 reported a higher prevalence of carotid plaques among patients with previous unprovoked deep vein thrombosis compared with patients with provoked deep vein thrombosis and hospitalized controls. In their study, participants tended to be older, and plaques were defined differently compared with our study. Hong et al 17 found the presence of coronary artery calcium, a marker of systemic atherosclerosis, to be significantly associated with VTE. However, the case-control design of these latter 2 studies makes the temporal sequence of events difficult to establish. Furthermore, both studies used other hospitalized patient controls, which reduces generalizability and introduces possible selection bias. 18 The discriminatory effect of TPA and IMT measurements on MI and VTE found in our study indicates that atherosclerosis is not an important risk factor in the pathogenesis of VTE.
Several studies have demonstrated an association between VTE and overt cardiovascular disease. 1, [19] [20] [21] In a meta-analysis by Becattini et al, 21 patients with unprovoked VTE had a 1.5fold increased risk of cardiovascular disease compared with control groups. However, prospective studies report varying results on atherosclerotic risk factors and VTE, with a majority of null findings. [4] [5] [6] 22 To date, 2 large cohort studies have used a competing risk approach to assess the effect of traditional cardiovascular risk factors on arterial and venous thrombosis. 3, 23 In both the Tromsø Study and the Physicians' Health Study, hypertension, dyslipidemia, diabetes mellitus, smoking, and physical activity (inverse) were significantly associated with risk of MI but not with VTE. 3, 23 Because established cardiovascular risk factors (apart from obesity) fail to show a consistent association with VTE, it is plausible that the link between venous and arterial thrombosis is explained by mechanisms of thrombus formation and hypercoagulability rather than atherosclerosis. Spencer et al 20 found a 3-fold increase in risk of MI in patients with VTE compared with controls, but only in participants aged <40 years, who were generally lacking atherosclerotic risk factors.
Major strengths of this study include the large number of participants recruited from a general population, the high attendance rate, the prospective design, and the measurements of potential confounders. The municipality of Tromsø is served by a single hospital, and the supplemental use of the National Causes of Death registry and the National population registry allowed for a rigorous case validation for both end points.
Some limitations also merit consideration. TPA and IMT were measured only in the right carotid artery, whereas measurements on both sides might have been more representative of the individual's atherosclerotic status. Also, both the carotid measurements and potential confounders were assessed at baseline only, and these factors could have changed over time and thereby resulted in underestimations of the true effects in our study. Thus, we cannot rule out the possibility that changes in carotid atherosclerosis over time may be associated with VTE. Even so, this same limitation is present for MI. In general, comparing the effect of carotid atherosclerosis on risk of MI and VTE within the same population reduces the risk of nondifferential misclassification bias because it is likely that the degree of random misclassification of exposure was similar with regard to both outcomes. In conclusion, our study showed that carotid atherosclerosis is a strong risk factor for MI but not for VTE.
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Venous thrombosis is a common and potentially fatal disease. Because ≤50% of events occur without known predisposing conditions, identifying novel risk factors is important. Although several previous studies have suggested that venous and arterial thrombosis share risk factors, our study is the first to use a competing risk method to evaluate the effect of carotid atherosclerosis, a known risk factor for arterial thrombotic disease, on venous thromboembolism and myocardial infarction within the same population. In a competing risk model, one eliminates the possibility of one outcome (venous thrombosis) influencing the risk of another (myocardial infarction); thus, the direct effect of the risk factor in question (carotid atherosclerosis) is assessed.
Significance

